• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Our epadistas organised several events to mark World Alzheimer’s Day

2018-09-28News

World Alzheimer’s Month is the international campaign to raise awareness and challenge the stigma that surrounds dementia. September 2018 is World Alzheimer’s Month (WAM), including World Alzheimer’s Day (WAD) on 21 September.  The 7th global WAM utilises the theme of “Every 3 seconds” to emphasise the huge global impact of dementia worldwide.

As every year on World Alzheimer’s Day, many Alzheimer associations and other stakeholders around the world organised advocacy and information provision events to show the global impact of dementia and promote dementia awareness. September has been a busy month for our EPAD partners and TDCs, with a number of meetings and events taking place to join the World Alzheimer’s Month campaign. This year, we are glad to report some activities done by our Epadistas.

BBRC, Pasqual Maragall Foundation (Barcelona, Spain) 

The Pasqual Maragall Foundation, which prompted the Barcelonaβeta Brain Research Center (BBRC), is celebrating its 10th anniversary. With the aim to “bring back” memories to its founder Pasqual Maragall, who was diagnosed with Alzheimer’s disease in 2007 and created the foundation one year later, the foundation launched a book in which 40 friends of the former mayor of Barcelona and president of Catalonia remember an anecdote with him. Part of the benefits of the book will go to the research on Alzheimer’s prevention carried out at the BBRC. The book was presented the 20th of September in Barcelona, in an event with more than 600 attendants.

Also coinciding with the World Alzheimer’s Day, the Pasqual Maragall Foundation, together with “la Caixa” Banking Foundation, covered the names of the plaques of several streets in the Ópera neighbourhood in Madrid. The aim of the street campaign was to raise awareness about the symptoms of Alzheimer’s disease, such as disorientation, and the need to invest more money on research. You can see the video of the campaign here.

Biogen (Baar, Switzerland)

This year, on World Alzheimer’s Day and through World Alzheimer’s Month, Biogen engaged in various educational and communications initiatives, to share the depth of commitment, passion and ambition of the people working in Alzheimer’s. From research & development, medical and patient advocacy colleagues across the company delivered a message of defiance in bringing innovation to the Alzheimer’s disease community. Specifically, Biogen partnered with the European Federation of Pharmaceutical Industries and Associations (EFPIA) to publish pledges committing to the clinical research and tackling of stigma in Alzheimer’s disease. Throughout September Biogen also worked with RAND corporation to highlight health system readiness in Europe to new Alzheimer’s innovations. Outside of Europe, Biogen supported several of the Alzheimer’s Association “Walk to End Alzheimer’s” in the US. As a company Biogen is proud to demonstrate its commitment to the millions of people living with Alzheimer’s disease and their loved ones. Biogen has made a long-term commitment to furthering Alzheimer’s disease research and treatment, and remains driven by the profound unmet needs of patients, families, caregivers and society.

CHUT (Toulouse, France)

Together with the French Alzheimer association « France Alzheimer » of its department, the CHUT organised an event on World Alzheimer’s Day entitled «Changeons de regard pour comprendre et agir ». Dr Pierre Jean Ousset gave a presentation on Alzheimer’s disease. The programme could be downloaded here.

CHRU (Lille, France)

Several events were organised on World Alzheimer’s Day in Lille including a meeting to celebrate the 25 years of the Bailleul advanced consultation. This meeting organised for the general public at the “centre médical des monts de flandres” involved many CHRU’s consultants. Moreover, CHRU had a great media coverage. TF1, the private national French TV channel considered as the most popular domestic network, diffused a TV reportage on their “centre de la mémoire”.

IRCCS Fatebenefratelli (Brescia, Italy)

As every year for the World Alzheimer’s Day, the well-known Millennium gym in Brescia – located in front of the Brescia’s Institute “IRCCS Centro San Giovanni di Dio Fatebenefratelli” – organises an event called “Move for Alzheimer / Muoviamoci per l’Alzheimer” to raise funds and support research for Alzheimer’s disease. This year, the event lasted one week (September 13-21) and the program consisted of a series of sporting events aimed at the entire population, such as pole dance, soccer and yoga. During this occasion, some researchers of the IRCCS Fatebenefratelli took the opportunity to explain the research activity of the Institute at dedicated stands.

On September 21, an informational meeting aimed at patients and their relatives was also organised at the IRCCS Fatebenefratelli to increase the awareness on Alzheimer’s disease and patient’s care. The Chief Medical Officer, the director-General, a clinician and a qualified trainer of the institute had the opportunity to be speakers at this event.

Janssen (Beerse, Belgium)

Each year on September 21, which marks World Alzheimer Day, an international campaign is being organised to raise awareness and challenge the stigma surrounding dementia. Janssen R&D Neuroscience organised several internal initiatives to bring attention to this disease. A fourth edition of the Janssen Talk Café Dementia was hosted at Janssen Beerse, followed by a play about caregiving. For this edition, Janssen R&D Neuroscience focused on ‘treatment of dementia – the key to success’. In this interactive session, Janssen employees were invited to get more insight into what is known about Alzheimer’s disease treatments. Additionally, cupcakes were sold to support Alzheimer’s research (Stichiting Alzheimer Onderzoek).

Karolinska Institutet (Stockholm, Sweden)

On Sept 21st Karolinska Institutet and Theme Aging, Karolinska University Hospital, recognised the seventh World Alzheimer’s Day. They took the opportunity to attend lectures from frontiers, among others Prof Miia Kivipelto and her team, within the field of Alzheimer prevention, diagnostics, and treatment. In a parallel event, sponsored by the Swedish Alzheimer Foundation, Associate Prof Alina Solomon gave a lecture regarding how we can prevent dementia and multi-domain interventions. After that, a joint visit to their new Memory Clinic at Karolinska University Hospital Solna was organised. During the evening of the same day Prof Kivipelto traveled to Helsinki, Finland to participate in the gala event of Alzheimer Association Finland. She received the first time ever gold medal awarded for her contributions for dementia prevention and patient care.

Paris Nord GH de Lariboisiere (Paris, France)

For the World Alzheimer’s Day, France Alzheimer organised an event from 21st September to 23rd September in Paris. In the space of these three days, several topics were presented and discussed including adapted physical activities, prevention, early diagnosis, treatments, scientific research, nutrition and carers in professional activity. 33 hours of workshops and 17 presentations were planned on the occasion of the 6th edition of the “Alzheimer Village”. The program could be downloaded here. We are glad to see that thee members of the Paris Nord GH de Lariboisiere contributed to this event. On 22nd September, Dr Julien Dumurgier and Aurelie Meauzoone gave a presentation about the early diagosis. Pr Claire Paquet reported about the frontotemporal degenerations and the Lewy body disease.

Tayside (Dundee, Scotland)

In Tayside, the team had an exhibition stall promoting dementia research in the Clinical Research Centre at Ninewells Hospital in Dundee. In addition, there’s been some activity on their social media accounts.

UNIGE (Geneva, Switzerland)

On the occasion of World Alzheimer’s Day on September 21st 2018, a Geneva’s Alzheimer day has been organised in the University Hospitals of Geneva (HUG), by the Swiss Association for Alzheimer’s Research (APRA). The programme could be downloaded here. During this day, a series of talks took place in the presence of the officials of Geneva’s city, among which a presentation of the Geneva Centre de la Mémoire. During his presentation, Prof. Frisoni explained the role of the center as a central point of contact for patients and researchers and gave exposure to the research projects led in Geneva. To complete this day, a concert in favor of the APRA 30th birthday was given in order to unite the different stakeholders around a festive event.

History of World Alzheimer’s Day

World Alzheimer’s Day (21st September) was launched in 1994 to mark the 10th anniversary of Alzheimer’s disease International (ADI), who is the umbrella international organisation of 90 Alzheimer associations around the world.  Originally, this day is part of World Alzheimer’s Month, where organisations coordinate to create global messages about dementia for the media, key stakeholders and policy makers. ADI coordinates the World Alzheimer’s Month campaign through their members, supporters and corporate partners. September 2018 marked the seventh World Alzheimer’s Month campaign. Its primary objective is to reach out to as many countries as possible, showing the global impact of dementia and promoting dementia awareness and what we can do to help support those living with the disease. The theme for this year’s World Alzheimer’s Month campaign is Every 3 seconds. Every 3 seconds someone in the world develops dementia.

 

 

 

Share this post
FacebookTwitterLinkedInGoogle+
Related posts
Analysis of multiple steroids in saliva in the EPAD study
2023-03-02
Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
2023-01-16
Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
2022-12-09
Bruno Steinkraus
Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
2022-11-25
New paper defining and discussing the substantial assets of the EPAD project is out!
2022-11-23
New paper using the EPAD data for an analysis of sleep quality and efficiency
2022-11-03
Latest News
  • Analysis of multiple steroids in saliva in the EPAD study
    2023-03-02
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
    2023-01-16
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
    2022-12-09
  • Bruno Steinkraus
    Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
    2022-11-25
  • New paper defining and discussing the substantial assets of the EPAD project is out!
    2022-11-23
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

📢@imi_epnd has launched its Cohort Catalogue, a central, open & accessible repository for researchers to discover studies & search metadata. Currently 67 research cohorts from 17 countries across Europe including @IMI_EPAD-VUmc participants ⬇️ eurekalert.org/news-releases/… twitter.com/imi_epnd/statu…

reply retweet favorite
9:56 am · 2023-03-14
Twitter
EPAD
EPAD
@IMI_EPAD

NEW paper published in @MetabolitesMDPI using LC-MS/MS method to determine salivary steroids using @IMI_EPAD samples. Congratulations @GregorySarah @zinghomer @guider50 @scottgdenham👏 @EdMassSpecCore @IMI2_NEURONET @IHIEurope #mdpimetabolites mdpi.com/2133518

reply retweet favorite
12:55 pm · 2023-03-02
Twitter
EPAD
EPAD
@IMI_EPAD

"There is a growing consensus that individual research results that are potentially relevant should be reported to research participants” & “Our work was positively received by the EPAD partners, and formed the basis for the set-up & the conduct of the study,” said Eline Bunnik

reply retweet favorite
10:32 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the @IHIEurope newsletter including a spotlight on IMI results from projects on diabetes @HypoResolve and #Alzheimer’s disease @IMI_EPAD @IMI_AMYPAD ⬇️ Read it: bit.ly/3jeaxdM twitter.com/IHIEurope/stat…

reply retweet favorite
10:30 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

17 centres have contributed to the @IMI_AMYPAD Prognostic Study across 11 Parent Cohorts including @IMI_EPAD. Have a look on the latest AMYPAD paper published in @FrontNeurol ⬇️ twitter.com/IMI_AMYPAD/sta…

reply retweet favorite
8:19 am · 2023-01-30
Workstream Progress
Workstream 120%
Workstream 232%
Workstream 310%
Workstream 446%
Contact us

Submitclear

Recent Posts
  • Analysis of multiple steroids in saliva in the EPAD study
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
  • Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
  • New paper defining and discussing the substantial assets of the EPAD project is out!
Recent Comments
  • The EPAD genomic data is now available on the Alzheimer’s Disease Workbench on The EPAD genomic data is now available on the Alzheimer’s Disease Workbench
  • ADDI celebrates one year of achievements – Neuronet on ADDI celebrates one year of achievements
  • EPAD dataset is now available on the Alzheimer’s Disease Workbench on The final EPAD dataset is now available on the Alzheimer’s Disease Workbench
  • The final EPAD dataset is now available to the entire research community on The final EPAD dataset is now available to the entire research community
  • The ERC has awarded an ERC grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease – Neuronet on New ERC starting grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease
Archives
  • March 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
Categories
  • EPAD Academy
  • News
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT